William A. Carroll
About
William A. Carroll is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine.
According to data from OpenAlex, William A. Carroll has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Organic Chemistry and 14 papers in Pathology and Forensic Medicine. Recurrent topics in William A. Carroll's work include Cardiac Ischemia and Reperfusion (14 papers), Ion channel regulation and function (11 papers) and Adenosine and Purinergic Signaling (10 papers). William A. Carroll is often cited by papers focused on Cardiac Ischemia and Reperfusion (14 papers), Ion channel regulation and function (11 papers) and Adenosine and Purinergic Signaling (10 papers). William A. Carroll collaborates with scholars based in United States, United Kingdom and Czechia. William A. Carroll's co-authors include Michael F. Jarvis, Diana L. Donnelly‐Roberts, Murali Gopalakrishnan, Michael J. Coghlan, Marian T. Namovic, Paul A. Grieco, Prisca Honoré, Arturo Perez‐Medrano, Ying Wang and Connie R. Faltynek and has published in prestigious journals such as Journal of the American Chemical Society, Neuroscience and Journal of Medicinal Chemistry.
In The Last Decade
William A. Carroll
43 papers receiving 1.5k citations
Peers
William A. Carroll
Joel R. Gever United States
Xiao‐duo Ji United States
Sonja Hinz Germany
Anton D. Michel United Kingdom
Mah T. Shamim United States
Hiromi Nonaka Japan
Jörge Beleta Spain
Marc Pascal France
George Grayson United States
Zhoumou Chen United States
Citations per year, relative to William A. Carroll William A. Carroll (= 1×)
peers
Joel R. Gever
Countries citing papers authored by William A. Carroll
Since
Specialization
Citations
This map shows the geographic impact of William A. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Carroll more than expected).
Fields of papers citing papers by William A. Carroll
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by William A. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Carroll. The network helps show where William A. Carroll may publish in the future.
Co-authorship network of co-authors of William A. Carroll
This figure shows the co-authorship network connecting the top 25 collaborators of William A. Carroll. A scholar is included among the top collaborators of William A. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Carroll. William A. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Nelson, Derek W., Jennifer M. Frost, Karin Tietje, et al.. (2012). Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management. Bioorganic & Medicinal Chemistry Letters. 22(7). 2604–2608.
2.
Perez‐Medrano, Arturo, Diana L. Donnelly‐Roberts, Alan S. Florjancic, et al.. (2011). Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X7 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(11). 3297–3300.
3.
Hsieh, Gin C., Madhavi Pai, Prasant Chandran, et al.. (2010). Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. British Journal of Pharmacology. 162(2). 428–440.
4.
Donnelly‐Roberts, Diana L., Marian T. Namovic, Bruce W. Surber, et al.. (2008). [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors. Neuropharmacology. 56(1). 223–229.
5.
Florjancic, Alan S., Arturo Perez‐Medrano, Biqin Li, et al.. (2008). Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(6). 2089–2092.
6.
Carroll, William A., Diana L. Donnelly‐Roberts, & Michael F. Jarvis. (2008). Selective P2X7 receptor antagonists for chronic inflammation and pain. Purinergic Signalling. 5(1). 63–73.
7.
Buckner, Steven A., Kristi L. Whiteaker, Eduardo Molinari, et al.. (2007). Characterization of a novel ATP‐sensitive K + channel opener, A‐251179, on urinary bladder relaxation and cystometric parameters. British Journal of Pharmacology. 151(4). 467–475.
8.
Carroll, William A., Douglas Kalvin, Alan S. Florjancic, et al.. (2007). Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 4044–4048.
9.
Fryer, Ryan M., Lee C. Preusser, Michael E. Brune, et al.. (2005). Pharmacological Characterization of the Novel Dihydropyridine Potassium Channel Opener, (9R)-9-(3-Iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the Regulation of Cardiovascular Function in Conscious and Anesthetized Beagle Dogs. Journal of Cardiovascular Pharmacology. 46(2). 232–240.
10.
Lange, U, Annette Hambrock, Cornelia Löffler‐Walz, et al.. (2004). Interaction of a novel dihydropyridine K+ channel opener, A‐312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075. British Journal of Pharmacology. 141(7). 1098–1105.
11.
Gopalakrishnan, Murali, Steven A. Buckner, Char‐Chang Shieh, et al.. (2004). In vitro and in vivo characterization of a novel naphthylamide ATP‐sensitive K+ channel opener, A‐151892. British Journal of Pharmacology. 143(1). 81–90.
12.
Drizin, Irene, Robert J. Altenbach, Steven A. Buckner, et al.. (2004). Structure–activity studies for a novel series of tricyclic dihydropyridopyrazolones and dihydropyridoisoxazolones as KATP channel openers. Bioorganic & Medicinal Chemistry. 12(8). 1895–1904.
13.
Turner, Sean, William A. Carroll, Murali Gopalakrishnan, et al.. (2003). The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: synthesis and structure–activity relationships of 2-amino-4-azaindoles. Bioorganic & Medicinal Chemistry Letters. 13(12). 2003–2007.
14.
Gopalakrishnan, Murali, Thomas R. Miller, Steven A. Buckner, et al.. (2003). Pharmacological characterization of a 1,4‐dihydropyridine analogue, 9‐(3,4‐dichlorophenyl)‐3,3,6,6‐tetramethyl‐3,4,6,7,9,10‐hexahydro‐1,8(2H,5H)‐acridinedione (A‐184209) as a novel KATP channel inhibitor. British Journal of Pharmacology. 138(2). 393–399.
15.
Turner, Sean, William A. Carroll, Michael E. Brune, et al.. (2003). Structure–activity relationship of a novel class of naphthyl amide KATP channel openers. Bioorganic & Medicinal Chemistry Letters. 13(10). 1741–1744.
16.
Brune, Michael E., Thomas A. Fey, Jorge D. Brioni, et al.. (2002). (−)-(9 S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4 H)-one 1,1-Dioxide (A-278637): A Novel ATP-Sensitive Potassium Channel Opener Efficacious in Suppressing Urinary Bladder Contractions. II. In Vivo Characterization. Journal of Pharmacology and Experimental Therapeutics. 303(1). 387–394.
17.
Drizin, Irene, Mark W. Holladay, Sujatha M. Gopalakrishnan, et al.. (2002). Structure–Activity studies for a novel series of tricyclic dihydropyrimidines as KATP channel openers (KCOs). Bioorganic & Medicinal Chemistry Letters. 12(11). 1481–1484.
18.
Carroll, William A., et al.. (2001). Two Novel and Potent 3-[(o-Methoxyphenyl)piperazinylethyl]-5-phenylthieno[2,3-d]pyrimidine-2,4-diones Selective for the α1D Receptor. Bioorganic & Medicinal Chemistry Letters. 11(9). 1119–1121.
19.
Meyer, Michael D., Robert J. Altenbach, Fatima Z. Basha, et al.. (2000). Structure−Activity Studies for a Novel Series of Tricyclic Substituted Hexahydrobenz[e]isoindole α1A Adrenoceptor Antagonists as Potential Agents for the Symptomatic Treatment of Benign Prostatic Hyperplasia (BPH). Journal of Medicinal Chemistry. 43(8). 1586–1603.
20.
Carroll, William A., et al.. (1997). Competitive ortho metalation effects: The kinetic and thermodynamic lithiation of 3-(tert-butoxycarbonyl)amino-4-carbomethoxythiophene. Tetrahedron Letters. 38(15). 2637–2640.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Joel R. Gever Breakdown of academic impact, for papers by Xiao‐duo Ji Breakdown of academic impact, for papers by Sonja Hinz Breakdown of academic impact, for papers by Anton D. Michel Breakdown of academic impact, for papers by Mah T. Shamim Breakdown of academic impact, for papers by Hiromi Nonaka Breakdown of academic impact, for papers by Jörge Beleta Breakdown of academic impact, for papers by Marc Pascal Breakdown of academic impact, for papers by George Grayson Breakdown of academic impact, for papers by Zhoumou Chen